Linked Data API

Show Search Form

Search Results

1131666
star this property registered interest false more like this
star this property date less than 2019-06-12more like thismore than 2019-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Arthritis: Diagnosis more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of training for GPs in the early diagnosis of rheumatoid arthritis. more like this
star this property tabling member constituency Rochdale more like this
star this property tabling member printed
Tony Lloyd more like this
star this property uin 263716 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-17more like thismore than 2019-06-17
star this property answer text <p>General practice is where most patients with musculoskeletal conditions, including rheumatoid arthritis (RA) are likely to be managed, and the condition is identified as a key area of clinical knowledge in the Royal College of General Practitioners’ Advanced Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the United Kingdom within the context of the National Health Service and is a key part of general practitioner’s qualifying exams.</p><p>No specific assessment has been made on the adequacy of access to specialist rheumatologists, however the National institute for Health and Care Excellence’s (NICE) Quality Standard ‘Rheumatoid arthritis in over 16s’, updated in July 2018, emphasises the need for early for urgent referral to a specialist rheumatologist on suspicion of rheumatoid arthritis within three weeks.</p><p>In May 2018, a new three-year Rheumatoid and Early Inflammatory Arthritis Audit was commissioned by the Healthcare Quality Improvement Partnership. The Audit aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments with suspected inflammatory arthritis in England and Wales using criteria derived from sources, including the NICE rheumatoid arthritis Quality Standard. This includes assessment against the NICE standard stating that patients with suspected with RA should be seen within three weeks of referral to a rheumatology service.</p><p>More information can be found at the following link:</p><p><a href="http://www.rheumatology.org.uk/Knowledge/Excellence/Audits" target="_blank">www.rheumatology.org.uk/Knowledge/Excellence/Audits</a></p><p>The findings of the Audit are due to be published in October 2019. However, previous Audit reports can be found at the following link:</p><p><a href="http://www.hqip.org.uk/national-programmes/a-z-of-nca/arthritis-rheumatoid-and-early-inflammatory" target="_blank">www.hqip.org.uk/national-programmes/a-z-of-nca/arthritis-rheumatoid-and-early-inflammatory</a></p><p> </p><p> </p>
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 263717 more like this
star this property question first answered
less than 2019-06-17T14:54:50.673Zmore like thismore than 2019-06-17T14:54:50.673Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
450
unstar this property label Biography information for Tony Lloyd more like this
1131669
star this property registered interest false more like this
star this property date less than 2019-06-12more like thismore than 2019-06-12
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Rheumatology more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to specialist rheumatologists. more like this
star this property tabling member constituency Rochdale more like this
star this property tabling member printed
Tony Lloyd more like this
star this property uin 263717 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-17more like thismore than 2019-06-17
star this property answer text <p>General practice is where most patients with musculoskeletal conditions, including rheumatoid arthritis (RA) are likely to be managed, and the condition is identified as a key area of clinical knowledge in the Royal College of General Practitioners’ Advanced Knowledge Test (AKT) content guide. The AKT is a summative assessment of the knowledge base that underpins general practice in the United Kingdom within the context of the National Health Service and is a key part of general practitioner’s qualifying exams.</p><p>No specific assessment has been made on the adequacy of access to specialist rheumatologists, however the National institute for Health and Care Excellence’s (NICE) Quality Standard ‘Rheumatoid arthritis in over 16s’, updated in July 2018, emphasises the need for early for urgent referral to a specialist rheumatologist on suspicion of rheumatoid arthritis within three weeks.</p><p>In May 2018, a new three-year Rheumatoid and Early Inflammatory Arthritis Audit was commissioned by the Healthcare Quality Improvement Partnership. The Audit aims to improve the quality of care for people living with inflammatory arthritis, collecting information on all new patients over the age of 16 in specialist rheumatology departments with suspected inflammatory arthritis in England and Wales using criteria derived from sources, including the NICE rheumatoid arthritis Quality Standard. This includes assessment against the NICE standard stating that patients with suspected with RA should be seen within three weeks of referral to a rheumatology service.</p><p>More information can be found at the following link:</p><p><a href="http://www.rheumatology.org.uk/Knowledge/Excellence/Audits" target="_blank">www.rheumatology.org.uk/Knowledge/Excellence/Audits</a></p><p>The findings of the Audit are due to be published in October 2019. However, previous Audit reports can be found at the following link:</p><p><a href="http://www.hqip.org.uk/national-programmes/a-z-of-nca/arthritis-rheumatoid-and-early-inflammatory" target="_blank">www.hqip.org.uk/national-programmes/a-z-of-nca/arthritis-rheumatoid-and-early-inflammatory</a></p><p> </p><p> </p>
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property grouped question UIN 263716 more like this
star this property question first answered
less than 2019-06-17T14:54:50.72Zmore like thismore than 2019-06-17T14:54:50.72Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
450
unstar this property label Biography information for Tony Lloyd more like this
1133166
star this property registered interest false more like this
star this property date less than 2019-06-19more like thismore than 2019-06-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether patients whose prescription for a cannabis-based medical product is blocked by an NHS trust can appeal that decision. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi more like this
star this property uin 266861 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-27more like thismore than 2019-06-27
star this property answer text <p>In line with routine clinical practice patients wishing to seek a second opinion will be supported to do so. In the first instance clinicians should refer patients for a second opinion using their established protocols. If it is not possible to obtain a second or further opinion using established protocols then National Health Service trusts are instructed to contact their NHS England Regional Medical Director who will be able to offer further advice around a referral route. The NHS England Regional Medical Directors will support NHS trusts in identifying a suitable NHS specialist for a second opinion. Processes may differ in Scotland, Wales and Northern Ireland.</p> more like this
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-27T12:42:09.417Zmore like thismore than 2019-06-27T12:42:09.417Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1133167
star this property registered interest false more like this
star this property date less than 2019-06-19more like thismore than 2019-06-19
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Cannabis: Medical Treatments more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what recent discussions his Department has had with (a) NHS England, (b) drug manufacturers and (c) the National Institute for Health and Care Excellence on funding for licensed cannabis-based products. more like this
star this property tabling member constituency Gower more like this
star this property tabling member printed
Tonia Antoniazzi more like this
star this property uin 266862 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-27more like thismore than 2019-06-27
star this property answer text <p>The Department is in regular contact with the National Institute for Health and Care Excellence (NICE) and NHS England colleagues about a range of issues and has not met with drug manufacturers on funding of licensed cannabis-based products.</p><p>Sativex is currently the only licensed cannabis-based product available in the United Kingdom. NICE considered the clinical and cost effectiveness of Sativex in the development of its clinical guideline on the management of multiple sclerosis published in 2014. NICE was not able to recommend Sativex as a cost-effective use of NHS resources for the treatment of spasticity in people with multiple sclerosis. Sativex is not therefore routinely funded by the NHS in England for use in the treatment of multiple sclerosis, although clinicians are able to make a request for exceptional funding for individual patients who they think may benefit from treatment.</p><p>NICE has been asked to develop clinical guidelines on cannabis-based products for medicinal use and is expected to look at the clinical and cost effectiveness of treatments, including Sativex, as part of this work. This is expected to be published by October 2019.</p>
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-27T12:43:17.543Zmore like thismore than 2019-06-27T12:43:17.543Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4623
unstar this property label Biography information for Tonia Antoniazzi more like this
1138460
star this property registered interest false more like this
star this property date less than 2019-07-11more like thismore than 2019-07-11
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Smoking more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, how many and what proportion of Clinical Commissioning Groups do not allow varenicline and other stop smoking treatments to be prescribed to patients in primary care; and if he will make a statement. more like this
star this property tabling member constituency Corby more like this
star this property tabling member printed
Tom Pursglove more like this
star this property uin 276206 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-18more like thismore than 2019-07-18
star this property answer text <p>NHS England has advised that, because this is a locally commissioned service, they do not hold this information centrally.</p> more like this
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-18T09:24:56.93Zmore like thismore than 2019-07-18T09:24:56.93Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
4369
unstar this property label Biography information for Tom Pursglove more like this
1125739
star this property registered interest false more like this
star this property date less than 2019-05-09more like thismore than 2019-05-09
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Voluntary Scheme for Branded Medicines Pricing and Access more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether his Department has plans to involve patient organisations in setting the success factors for the 2019 Voluntary Scheme for Branded Medicines Pricing and Access as part of the first operational review meeting. more like this
star this property tabling member constituency Carshalton and Wallington more like this
star this property tabling member printed
Tom Brake more like this
star this property uin 252468 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-17more like thismore than 2019-05-17
star this property answer text <p>The Department has engaged with patient organisations on multiple occasions as part of the negotiation and implementation of the voluntary scheme. The Department is currently working closely with NHS England and the Association of the British Pharmaceutical Industry to develop success factors for the 2019 voluntary scheme and will keep patient groups informed on progress.</p> more like this
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-05-17T12:34:07.99Zmore like thismore than 2019-05-17T12:34:07.99Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
151
unstar this property label Biography information for Tom Brake more like this
1129141
star this property registered interest false more like this
star this property date less than 2019-06-03more like thismore than 2019-06-03
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Animal Products: Labelling more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the costs which will be accrued as a result of the cost of changing stamps bearing the UK's ISO mark for animal products from EC to GB if the UK leaves the EU. more like this
star this property tabling member constituency Carshalton and Wallington more like this
star this property tabling member printed
Tom Brake more like this
star this property uin 258880 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-11more like thismore than 2019-06-11
star this property answer text <p>As part of preparations for leaving the European Union, the Food Standards Agency (FSA) has taken steps to change the United Kingdom’s health and identification marks so that products of animal origin can continue to be exported to the EU and non-EU countries, should the UK leave the EU in a no deal situation.</p><p>FSA operational staff apply the health mark, sometimes referred to as the health stamp to meat carcases to indicate that the product has been inspected and passed fit for human consumption. The FSA has procured and distributed new health marks to all its operational staff located in England and Wales at an approximate cost of £50,000.</p><p>Further guidance on the form of the new health and identification mark is publicly available on the FSA’s website at the following link:</p><p><a href="https://www.food.gov.uk/business-guidance/eu-exit-changes-to-health-and-identification-marks" target="_blank">https://www.food.gov.uk/business-guidance/eu-exit-changes-to-health-and-identification-marks</a></p><p> </p>
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-11T15:33:20.407Zmore like thismore than 2019-06-11T15:33:20.407Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
151
unstar this property label Biography information for Tom Brake more like this
1130460
star this property registered interest false more like this
star this property date less than 2019-06-06more like thismore than 2019-06-06
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Influenza: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the level of uptake of the most recent flu vaccine. more like this
star this property tabling member constituency Carshalton and Wallington more like this
star this property tabling member printed
Tom Brake more like this
star this property uin 261072 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-14more like thismore than 2019-06-14
star this property answer text <p>Cumulative influenza vaccine uptake is collected and evaluated by Public Health England (PHE) nationally and locally. The 2018 to 2019 season included the extension of the childhood programme to all those aged nine rising to 10 years old as well as the phased delivery of the newly licensed adjuvanted vaccine for those aged 65 and over.</p><p>The national school-age vaccination programme achieved the highest levels of vaccine uptake since it started (60.8%, 2,461,563/4,051,698 in 2018/19, compared to 59.5% in 2017/18 1,998,538/3,360,997). Vaccine uptake for the pre-school children’s influenza vaccine programme has also increased further compared to previous seasons. The following table shows uptake figures for 2018/19 and 2017/18.</p><p>Uptake in adult target groups was similar or slightly lower compared to recent seasons and further work is needed to identify underpinning reasons so that uptake can be improved.</p><p>Comparison of flu uptake in groups vaccinated in general practice.</p><table><tbody><tr><td><p>Group</p></td><td><p>2018/19</p></td><td><p>2017/18</p></td></tr><tr><td><p>65 and over</p></td><td><p>72.0% 7,260,596/10,087,873/-</p></td><td><p>72.9% 7,309,125/10,032,613</p></td></tr><tr><td><p>At risk</p></td><td><p>48.0% 3,276,592/6,820,919</p></td><td><p>49.7% 3,353,724/6,742,316</p></td></tr><tr><td><p>Pregnant</p></td><td><p>45.2% 293,359/649,233</p></td><td><p>47.0% 318,057/676,159</p></td></tr><tr><td><p>Two and three year olds combined</p></td><td><p>44.9% 593706/1,322,663</p></td><td><p>44.0% 585791/1,330,150</p></td></tr></tbody></table><p> </p><p>Source: <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804889/Seasonal_influenza_vaccine_uptake_in_GP_patients_1819.pdf" target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804889/Seasonal_influenza_vaccine_uptake_in_GP_patients_1819.pdf</a></p><p> </p><p>The frontline health care workers with direct patient care saw the highest uptake since the programme started in 2002/3 (70.3% in 2018/19 738488/1,051,038).</p>
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-14T12:54:11.043Zmore like thismore than 2019-06-14T12:54:11.043Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
151
unstar this property label Biography information for Tom Brake more like this
1134110
star this property registered interest false more like this
star this property date less than 2019-06-24more like thismore than 2019-06-24
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Influenza: Vaccination more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what estimate he has made of the (a) number of doses of flu vaccine required in winter 2019-20 and (b) proportion of those doses which will need to be sourced from outside the UK; and what plans he has in place to ensure the adequate supply of flu vaccine in the event that the UK leaves the EU without a deal on 31 October 2019. more like this
star this property tabling member constituency Carshalton and Wallington more like this
star this property tabling member printed
Tom Brake more like this
star this property uin 268344 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-06-27more like thismore than 2019-06-27
star this property answer text <p>Flu vaccines for people aged 18 years and older are procured directly from manufacturers and suppliers by providers, based on their local assessment of need. The procurement and distribution of flu vaccines for the children’s aspect of the national flu programme is managed by Public Health England (PHE). Doses of flu vaccine for 2019/20 is estimated using end of season for 2018/19 that are published on GOV.UK at the following links:</p><p><a href="https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-gp-patients-monthly-data-2018-to-2019" target="_blank">https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-gp-patients-monthly-data-2018-to-2019</a></p><p><a href="https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-healthcare-workers-monthly-data-2018-to-2019" target="_blank">https://www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-healthcare-workers-monthly-data-2018-to-2019</a></p><p>Seasonal flu vaccines for 2019/20 are currently being manufactured and due for delivery to the market in the autumn. Vaccine production is a complex and multi-stage process, which will involve a touch-point outside of the United Kingdom.</p><p>Officials continuously monitor the flu vaccine supply landscape to enable timely and appropriate action to be taken in the event of supply issues.</p><p>The Department, PHE and NHS England are in regular discussion with the manufacturers to ensure they have appropriate contingency plans in place to prepare for a potential ‘no deal’ scenario.</p>
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-06-27T15:20:53.833Zmore like thismore than 2019-06-27T15:20:53.833Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
151
unstar this property label Biography information for Tom Brake more like this
1137156
star this property registered interest false more like this
star this property date less than 2019-07-05more like thismore than 2019-07-05
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
unstar this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading Preventive Medicine more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what is his timeframe is for the publication of the Prevention Green Paper. more like this
star this property tabling member constituency Carshalton and Wallington more like this
star this property tabling member printed
Tom Brake more like this
star this property uin 273728 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-07-15more like thismore than 2019-07-15
star this property answer text <p>I refer the hon. Member to the answer given by the former Parliamentary Under Secretary of State (Steve Brine MP) to the hon. Member for Glasgow Central (Alison Thewliss MP) on 16 January 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-01-09/206879/" target="_blank">206879</a>.</p> more like this
unstar this property answering member constituency South Ribble remove filter
star this property answering member printed Seema Kennedy more like this
star this property question first answered
less than 2019-07-15T16:25:26.753Zmore like thismore than 2019-07-15T16:25:26.753Z
unstar this property answering member
4455
star this property label Biography information for Seema Kennedy more like this
star this property tabling member
151
unstar this property label Biography information for Tom Brake more like this